TVTX

TVTX

USD

Travere Therapeutics Inc. Common Stock

$34.510+1.910 (5.859%)

Echtzeitkurs

Healthcare
Biotechnologie
Vereinigte Staaten

Kursdiagramm

Loading Chart...

Schlüsselkennzahlen

Marktkennzahlen
Unternehmensfundamentaldaten
Handelsstatistiken

Marktkennzahlen

Eröffnung

$32.600

Hoch

$34.605

Tief

$32.310

Volumen

0.26M

Unternehmensfundamentaldaten

Marktkapitalisierung

3.1B

Branche

Biotechnologie

Land

United States

Handelsstatistiken

Durchschnittliches Volumen

2.25M

Börse

NGM

Währung

USD

52-Wochen-Spanne

Tief $12.91Aktuell $34.510Hoch $36.15

Ähnliche Nachrichten

BusinessWire

Travere Therapeutics to Participate at Upcoming Investor Conferences

Travere Therapeutics, Inc. (NASDAQ:TVTX) today announced that company management will participate in the following upcoming investor conferences: Guggenheim's 2nd Annual Healthcare Innovation Conference Presenting

Mehr anzeigen
Travere Therapeutics to Participate at Upcoming Investor Conferences
Analyst Upgrades

Piper Sandler Maintains Neutral on Travere Therapeutics, Raises Price Target to $35

Piper Sandler analyst Allison Bratzel maintains Travere Therapeutics with a Neutral and raises the price target from $26 to $35.

Mehr anzeigen
Piper Sandler Maintains Neutral on Travere Therapeutics, Raises Price Target to $35
Analyst Upgrades

TD Cowen Maintains Buy on Travere Therapeutics, Raises Price Target to $40

TD Cowen analyst Tyler Van Buren maintains Travere Therapeutics with a Buy and raises the price target from $30 to $40.

Mehr anzeigen
TD Cowen Maintains Buy on Travere Therapeutics, Raises Price Target to $40
BusinessWire

Travere Therapeutics to Report Third Quarter 2025 Financial Results

Travere Therapeutics, Inc. (NASDAQ:TVTX) today announced it will report third quarter 2025 financial results on Thursday, October 30, 2025, after the close of the U.S. financial markets. The Company will host a

Mehr anzeigen
Travere Therapeutics to Report Third Quarter 2025 Financial Results